Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures ...

Generation of additional clinical data allows for a more comprehensive assessment of the full potential of EVX-01, while strengthening the already strong clinical data packageWill provide insights ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...

Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

AI Offers a Second Look at Missed Signs. Dr. Tiffany Yu, assistant professor of Radiology at UCLA and lead author of the study, explains what makes IBCs so challenging: “These interval cancer ...

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine currently being evaluated as a treatment for advanced melanoma (skin cancer).

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine currently being evaluated as a treatment for advanced melanoma (skin cancer).